Fidelity Investments
TTPH

Fidelity Investments’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Fidelity Investments’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed – – 4416
2020
Q1 		$0 Hold
3
– – ﹤0.01% 4505
2019
Q4 		$0 Sell
3
-67
-96% -$215 ﹤0.01% 4463
2019
Q3 		$0 Buy
70
+2
+3% +$13 ﹤0.01% 4404
2019
Q2 		$1K Buy
68
+26
+62% +$478 ﹤0.01% 3682
2019
Q1 		$1K Hold
42
– – ﹤0.01% 3552
2018
Q4 		$1K Buy
42
+27
+180% +$1.06K ﹤0.01% 3468
2018
Q3 		$1K Buy
+15
New +$958 ﹤0.01% 3489
2018
Q1 		– Sell
-49,462
Closed -$6.23M – 2761
2017
Q4 		$6.23M Sell
49,462
-14,880
-23% -$1.91M ﹤0.01% 2105
2017
Q3 		$8.8M Sell
64,342
-2,460
-4% -$329K ﹤0.01% 1989
2017
Q2 		$9.53M Sell
66,802
-2,080
-3% -$321K ﹤0.01% 1963
2017
Q1 		$12.7M Sell
68,882
-29,555
-30% -$3.31M ﹤0.01% 1876
2016
Q4 		$7.93M Sell
98,437
-8
-0% -$633 ﹤0.01% 2049
2016
Q3 		$7.54M Hold
98,445
– – ﹤0.01% 2084
2016
Q2 		$8.47M Buy
98,445
+13
+0% +$1.19K ﹤0.01% 2038
2016
Q1 		$9.12M Sell
98,432
-8,960
-8% -$895K ﹤0.01% 1998
2015
Q4 		$21.5M Sell
107,392
-35
-0% -$6.98K ﹤0.01% 1655
2015
Q3 		$16M Sell
107,427
-47,945
-31% -$35.2M ﹤0.01% 1739
2015
Q2 		$147M Sell
155,372
-4,640
-3% -$3.79M 0.02% 849
2015
Q1 		$117M Buy
160,012
+11,301
+8% +$8.49M 0.01% 954
2014
Q4 		$118M Buy
148,711
+42,780
+40% +$23M 0.02% 920
2014
Q3 		$42.3M Sell
105,931
-6,866
-6% -$1.84M 0.01% 1370
2014
Q2 		$23.2M Buy
112,797
+5,715
+5% +$1.23M ﹤0.01% 1729
2014
Q1 		$21.7M Hold
107,082
– – ﹤0.01% 1710
2013
Q4 		$29M Hold
107,082
– – ﹤0.01% 1569
2013
Q3 		$24.4M Hold
107,082
– – ﹤0.01% 1618
2013
Q2 		$15.1M Buy
+107,082
New +$17M ﹤0.01% 1775

Other funds holding TTPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments's TTPH Position: Q2 2020 in Review

Fidelity Investments sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2020, closing a stake of 3 shares.

Fidelity Investments first reported a position in TTPH in Q2 2013 and held it in 26 quarters. The position peaked at $147M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q2 2020.

  • Fidelity Investments reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Fidelity Investments sold 3 Tetraphase Pharmaceuticals, Inc. shares in Q2 2020.
  • Fidelity Investments first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 26 quarters.
  • Fidelity Investments's Tetraphase Pharmaceuticals, Inc. position peaked at $147M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2020.

Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.